Chris Koopmans - 17 Jun 2024 Form 4 Insider Report for Marvell Technology, Inc. (MRVL)

Signature
Christopher Koopmans by Blair Walters as Attorney-in-Fact
Issuer symbol
MRVL
Transactions as of
17 Jun 2024
Net transactions value
-$367,100
Form type
4
Filing time
18 Jun 2024, 13:27:18 UTC
Previous filing
16 May 2024
Next filing
16 Jul 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVL Common Stock Sale $367,100 -5,000 -4.2% $73.42 115,318 17 Jun 2024 By Trust F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sales were made pursuant to a 10b5-1 Plan adopted by the Reporting Person on 07/14/2023.
F2 Total holdings includes 599 shares purchased on June 7, 2024 under the company's Employee Stock Purchase Plan (ESPP).
F3 Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.